Medical Laboratories

Medical Laboratories and FY2026 as a USAspending pair

NAICS 621511 and fiscal year 2026 meet here. $185,921,225.04 is the USAspending.gov obligation sum on the yearlyTrend row that carries both tags. It is not Medical Laboratories's nationwide all-year total of $2,178,881,667.33, not every federal dollar coded to FY2026, and not an outlay register. The packet does not split diagnostic from other medical-lab lines, or contract from assistance. 5,517 is an industry-extract action count: modifications and repeat awards add rows across years. Unique recipients are unpublished. This cell is not a lab census, a named-operator roster, or a test-volume ledger.

This page reports medical laboratories activity USAspending tagged to FY2026. The headline $185,921,225.04 sits beside an industry-wide obligation total of $2,178,881,667.33; the 8.5% share is arithmetic on those two packet facts, not a ranking of fiscal years as winners or losers. Obligations are not outlays. Named operators and test counts are unpublished. Quote NAICS 621511 and FY2026 together.

How USAspending labels Medical Laboratories in FY2026

USAspending labels NAICS 621511 as Medical Laboratories. That code produced $185,921,225.04 when crossed with fiscal year 2026. The industry-wide 621511 hub does not require a FY2026 filter. The year hub does not require Medical Laboratories. Only this tie applies both filters. The packet does not split diagnostic from other medical-lab lines, or contract from assistance. FY2026 incompleteness applies. Do not treat this row as a closed test-year book.

Correlation is not causation: FY2026 did not cause $185,921,225.04 by existing as a large or small budget year. The join is 621511 × FY2026 only. This cell is not a lab census, a named-operator roster, or a test-volume ledger. Do not invent contractors or award recipients to fill the gap. Campaign donations on FEC tables do not fund this USAspending cell; the datasets are separate. Five thousand five hundred seventeen industry-extract award records describe 621511 across years, not a FY2026 lab or test-volume census.

Questions

How much Medical Laboratories spending is obligated in FY2026?

USAspending.gov lists $185,921,225.04 in Medical Laboratories (NAICS 621511) obligations for FY2026. That yearlyTrend amount is 8.5% of the industry's $2,178,881,667.33 extract-wide total. It is an obligation join, not an outlay and not every federal dollar in FY2026. Unique recipients are unpublished.

Is $185,921,225.04 the entire Medical Laboratories USAspending total?

No. NAICS 621511's extract-wide total is $2,178,881,667.33. FY2026 is 8.5% of that book. Other fiscal-year rows for the same industry are separate cells. Do not add /industries/621511/ into this join. 5,517 award records stay on the industry extract, not on this yearlyTrend row.

Is $185,921,225.04 cash already paid in FY2026?

No. Obligations are commitments recorded on USAspending.gov awards. Outlays — money that actually left the Treasury — are a different concept and are not this packet's headline. Treating $185,921,225.04 as checks already cleared in FY2026 confuses those terms. Prefer the live industry and year hubs if the tables moved.

Is $185,921,225.04 the nationwide Medical Laboratories total?

No. $185,921,225.04 is the FY2026 yearlyTrend slice of NAICS 621511 only. Industry-wide Medical Laboratories is $2,178,881,667.33 on /industries/621511/ without this year filter. 8.5% describes this join. Outlays are unpublished. Source is USAspending.gov. USAspending.gov remains the source for NAICS 621511 in FY2026.